INS and early-onset autosomal dominant Alzheimer disease: Impaired insulin signaling increases risk of Alzheimer disease [2], cognitive disabilities in diabetes mellitus [3] and decreases cerebrocortical beta activity in overweight humans [4] whereas intranasal administration of insulin improves hippocampal-dependent memory function [5].